Novartis is looking to acquire Parsippany, N.J.-based drugmaker Medicines Co., people familiar with the matter told Bloomberg.

A dark money group that has spent over $1 million on advertisements criticizing drugmakers was created by executives from both the American Hospital Association and CVS Health, according to tax filings obtained by STAT.

Johnson & Johnson rushed to test its baby powder after the FDA found asbestos in a bottle. However, a Wall Street Journal review of lab reports released by J&J show the company's push for rapid testing complicated the test results. 

Democratic presidential hopeful Sen. Elizabeth Warren's plans to transition the country to a "Medicare for All" model include mention of seven specific drugs or categories of drugs that she plans to target to "dramatically lower" prices if elected. 

The number of drugmakers that filed for bankruptcy in 2019 was nearly three times more than the yearly average in the last decade, according to a BioPharma Dive review of data tracked by research firm BankruptcyData. 

A BioPharma Dive analysis identified 31 drugmakers at a high risk of going bankrupt in the next 12 months. 

Eight drugs approved by the FDA since Oct. 18:

Golden State Medical Supply is recalling 19 lots of ranitidine capsules, following a manufacturer's recall by East Windsor, N.J.-based Novitium Pharma.

The U.S. Supreme Court Nov. 18 denied to hear an appeal from disgraced pharmaceutical executive Martin Shkreli, according to CNBC.

Some of the physicians who helped Pfizer develop its recently-approved blockbuster heart disease drug, tafamidis, are now speaking out against the drug's $225,000 a year price tag, according to Bloomberg.